Radioiodinated Small-Molecule Tyrosine Kinase Inhibitor for HER2-Selective SPECT Imaging

One of the most clinically relevant molecular aberrations in breast cancer is overexpression of human epidermal growth factor receptor type 2 (HER2). We aimed to develop a radiolabeled tyrosine kinase inhibitor for HER2-targeted breast cancer imaging. In this study, a radioiodinated analog ((125/131...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Nucl Med
Autors principals: Tang, Longguang, Peng, Chenyu, Tang, Bowen, Li, Zijing, Wang, Xiangyu, Li, Jindian, Gao, Fei, Huang, Lumei, Xu, Duo, Zhang, Pu, Zhuang, Rongqiang, Su, Xinhui, Chen, Xiaoyuan, Zhang, Xianzhong
Format: Artigo
Idioma:Inglês
Publicat: Society of Nuclear Medicine 2018
Matèries:
Oncology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6126446/
https://ncbi.nlm.nih.gov/pubmed/29653973
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2967/jnumed.117.205088
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars